An "exercise in a pill" compound that activates the same molecular pathways your body turns on during endurance training. It improves how your cells' power plants (mitochondria) function, increases fat burning, and boosts muscle endurance -- without you needing to hit the gym (though you still should).
Dosing
10-50 mg by mouth daily. This is a research compound, so dosing protocols are still being figured out.
Benefit Profile
Published Research
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment.
Structural Pharmacology of Estrogen-Related Receptors.
Exploring the impact of estrogen-related receptor gamma on metabolism and disease.
Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists.
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
Addressing unmet needs in the treatment of COPD.
Recent advance in the design of small molecular modulators of estrogen-related receptors.
Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
A key role of the PGC-1α/ERR-α pathway in regulation of angiogenic factors in proliferative diabetic retinopathy.